These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3128105)

  • 21. Pentostatin (2'deoxycoformycin) for the treatment of lymphoid neoplasms.
    Ho AD; Thaler J; Willemze R; Lauria F; Derossi G; Kuse R; Stryckmans P; Blanc CM; Cataldo F; McVie G
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():60-2. PubMed ID: 2653520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deoxycoformycin in therapy of refractory lymphoid neoplasms.
    Ho AD; Thaler J; Kuse R; Willemze R; Mandelli F; Lauria F; Zittoun R; Stryckmans P
    Onkologie; 1988 Feb; 11(1):35-7. PubMed ID: 3283623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pentostatin in hairy cell leukemia: treatment by the special exception mechanism.
    Grem JL; King SA; Cheson BD; Leyland-Jones B; Wittes RE
    J Natl Cancer Inst; 1989 Mar; 81(6):448-53. PubMed ID: 2783980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful treatment of hair cell leukemia with 2'-deoxycoformycin after failure of interferons alpha or beta.
    Dutcher JP; Salva KM; Wiernik PH
    Am J Clin Oncol; 1990 Aug; 13(4):290-3. PubMed ID: 2198792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deoxycoformycin: a new chemotherapeutic agent of interest to dermatologists.
    Camisa C; Grever MR; Bouroncle B
    J Am Acad Dermatol; 1985 Jun; 12(6):1108-9. PubMed ID: 3874216
    [No Abstract]   [Full Text] [Related]  

  • 26. Hairy cell leukemia. A therapeutical update.
    Damasio EE; Pagnucco G; Federico M; Annino L; Chisesi T; Lamparelli T; Lauria F; Castoldi G; Resegotti L
    Haematologica; 1989; 74(2):205-18. PubMed ID: 2473014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repeated pentostatin (2'deoxycoformycin)-induced remissions in a patient with advanced chronic lymphocytic leukemia.
    Dillman RO; Yu AL; Qiao CN
    West J Med; 1988 Mar; 148(3):334-7. PubMed ID: 3259051
    [No Abstract]   [Full Text] [Related]  

  • 28. Hairy-cell leukemia: biology and treatment.
    Golde DW; Jacobs AD; Glaspy JA; Champlin RE
    Semin Hematol; 1986 Jul; 23(3 Suppl 1):3-9. PubMed ID: 3526560
    [No Abstract]   [Full Text] [Related]  

  • 29. Durable complete remissions after 2'-deoxycoformycin treatment in patients with hairy cell leukemia resistant to interferon alpha.
    Blick M; Lepe-Zuniga JL; Doig R; Quesada JR
    Am J Hematol; 1990 Mar; 33(3):205-9. PubMed ID: 2301379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The activity of deoxycoformycin (pentostatin) in refractory leukemias and lymphomas.
    Spiers AS
    Ann N Y Acad Sci; 1985; 451():138-41. PubMed ID: 3878115
    [No Abstract]   [Full Text] [Related]  

  • 31. Successful chemotherapy with deoxycoformycin in adult T-cell lymphoma-leukaemia.
    Daenen S; Rojer RA; Smit JW; Halie MR; Nieweg HO
    Br J Haematol; 1984 Dec; 58(4):723-7. PubMed ID: 6097297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response to deoxycoformycin in mature T cell malignancies.
    Ho AD; Stryckmans P; Zittoun R
    Br Med J (Clin Res Ed); 1987 Dec; 295(6611):1483-4. PubMed ID: 3500754
    [No Abstract]   [Full Text] [Related]  

  • 33. The role of pentostatin (2'-deoxycoformycin, dCF) in the management of lymphoproliferative malignancies.
    Spiers AS
    Blood Rev; 1987 Jun; 1(2):106-10. PubMed ID: 3332090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hairy cell leukemia: 30 years later].
    Grek V; Hay F; Beguin Y; Andrien F; Dokekias A; Fillet G
    Rev Med Liege; 1989 May; 44(10):358-64. PubMed ID: 2664964
    [No Abstract]   [Full Text] [Related]  

  • 35. Response duration and recovery of CD4+ lymphocytes following deoxycoformycin in interferon-alpha-resistant hairy cell leukemia: 7-year follow-up.
    Seymour JF; Talpaz M; Kurzrock R
    Leukemia; 1997 Jan; 11(1):42-7. PubMed ID: 9001417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic approaches to the treatment of hairy cell leukemia.
    Portlock CS
    Semin Oncol; 1986 Dec; 13(4 Suppl 5):55-9. PubMed ID: 3541219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Successful treatment with 2'-deoxycoformycin in a case of adult T-cell leukemia].
    Ishii M; Yamaguchi K; Yul LS; Oda T; Takatsuki K
    Rinsho Ketsueki; 1986 May; 27(5):780-3. PubMed ID: 3018324
    [No Abstract]   [Full Text] [Related]  

  • 38. The treatment of hairy cell leukemia.
    Golomb HM
    Blood; 1987 Apr; 69(4):979-83. PubMed ID: 3493818
    [No Abstract]   [Full Text] [Related]  

  • 39. Response to deoxycoformycin in T cell leukaemias.
    Catovsky D; Dearden C
    Br Med J (Clin Res Ed); 1988 Jan; 296(6618):356. PubMed ID: 2894233
    [No Abstract]   [Full Text] [Related]  

  • 40. Modulation of arabinosyladenine metabolism by 2'-deoxycoformycin in the therapy of human acute leukemia.
    Plunkett W; Nowak B; Feun LG; Benjamin RS; Keating M; Freirich EJ
    Adv Exp Med Biol; 1984; 165 Pt B():345-50. PubMed ID: 6372382
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.